Johnson & Johnson to Acquire Actelion for $30 Billion With Spin-Out of New R&D Company

Johnson & Johnson (NYSE:JNJ), the world’s largest healthcare holding company, with total registered worldwide sales of $71.89bn in 2016, has unveiled its intention to acquire the Swiss drug-maker Actelion Ltd (SIX:ATLN) with a move that will cost $30bn to the US company. Johnson & Johnson Johnson & Johnson is an American multinational medical devices, pharmaceutical and consumer packagedContinue reading “Johnson & Johnson to Acquire Actelion for $30 Billion With Spin-Out of New R&D Company”

A ghost in the Street?

Today, is Tech day. Snapchat’s parent company will be trading today in the New York Stock Exchange with a price tag of $17.0 per share for a total valuation of $24 billion. It is the most awaited and the largest IPO since Alibaba started trading in 2014 with a valuation of $168bn. American capital marketsContinue reading “A ghost in the Street?”